Clinical Trial Update: Codeine in Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating codeine in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Codeine (codeine)

Snippet

Sponsor: PriCara, Unit of Ortho-McNeil, Inc. | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED